Pune: GenePath lab receives Rs 2.5 crore grant to develop HPV detection device

On Nov 24, 2020

Pune: A city-based research laboratory, GenePath, has won a grant worth Rs 2.5 crore from United States–India Science & Technology Endowment Fund (USISTEF). The same has been granted for the production of a detection kit for the HPV (human papilloma virus), which causes cervical cancer in women.

The virus results in cervical cancer more than 90% of the time and is the second largest killer of women from cancer, impacting 570,000 women globally every year. India has the most cases globally with 97,000 cases and 63,000 deaths in 2019).

GenePath will develop the product over the next 24 months and the clinical laboratory in Pune will oversee the overall platform design, project management, system integration and clinical validation of each component of the platform.